366 related articles for article (PubMed ID: 11863377)
21. Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease.
Tang G; Xie H; Xu L; Hao Y; Lin D; Ren D
Am J Med Genet; 2002 May; 114(4):446-9. PubMed ID: 11992569
[TBL] [Abstract][Full Text] [Related]
22. [Association between polymorphism of alpha 1-antichymotrypsin and apolipoprotein E gene and Parkinson's disease in Shanghai Hans].
Hao Y; Xie H; Xu L
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1172-5. PubMed ID: 11769703
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia.
Akanji AO; Ohaeri JU; Al-Shammri SN; Fatania HR
Neuropsychobiology; 2009; 60(2):67-72. PubMed ID: 19752580
[TBL] [Abstract][Full Text] [Related]
24. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].
Zhao XP; Zheng HM; Xie HJ; Ding SJ; Ren DM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):339-41. PubMed ID: 15300629
[TBL] [Abstract][Full Text] [Related]
25. Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease.
Parsian A; Sinha R; Racette B; Zhao JH; Perlmutter JS
Parkinsonism Relat Disord; 2004 Jun; 10(4):213-9. PubMed ID: 15120095
[TBL] [Abstract][Full Text] [Related]
26. Association of APOE with Parkinson disease age-at-onset in women.
Buchanan DD; Silburn PA; Prince JA; Mellick GD
Neurosci Lett; 2007 Jan; 411(3):185-8. PubMed ID: 17113231
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis.
Mui S; Rebeck GW; McKenna-Yasek D; Hyman BT; Brown RH
Ann Neurol; 1995 Sep; 38(3):460-3. PubMed ID: 7668834
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
[TBL] [Abstract][Full Text] [Related]
29. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia.
Geschwind D; Karrim J; Nelson SF; Miller B
Ann Neurol; 1998 Jul; 44(1):134-8. PubMed ID: 9667603
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E and dementia in Parkinson disease: a meta-analysis.
Huang X; Chen P; Kaufer DI; Tröster AI; Poole C
Arch Neurol; 2006 Feb; 63(2):189-93. PubMed ID: 16476806
[TBL] [Abstract][Full Text] [Related]
31. Association between tau H2 haplotype and age at onset in frontotemporal dementia.
Borroni B; Yancopoulou D; Tsutsui M; Padovani A; Sawcer SJ; Hodges JR; Spillantini MG
Arch Neurol; 2005 Sep; 62(9):1419-22. PubMed ID: 16157749
[TBL] [Abstract][Full Text] [Related]
32. 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism can influence age at onset of Parkinson's disease.
Lin JJ; Yueh KC; Liu CS; Liu JT; Lin SZ
Acta Neurol Taiwan; 2007 Sep; 16(3):150-7. PubMed ID: 17966954
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients.
Bialecka M; Klodowska-Duda G; Kurzawski M; Slawek J; Gorzkowska A; Opala G; Bialecki P; Sagan L; Droździk M
Parkinsonism Relat Disord; 2008 Dec; 14(8):636-40. PubMed ID: 18362084
[TBL] [Abstract][Full Text] [Related]
34. [Apolipoprotein E gene polymorphisms and Alzheimer disease].
Chen D; Zhang JW; Zhang ZX; Zhao HL; Li XQ; Wu YN; Qu QM
Yi Chuan Xue Bao; 2003 Dec; 30(12):1167-70. PubMed ID: 14986436
[TBL] [Abstract][Full Text] [Related]
35. [The frequencies of apolipoprotein E genotypes in health and disease in the Croatian population--an overview of expectations and real results].
Pasalić D; Ferencak G; Grsković B; Stavljenic-Rukavina A
Acta Med Croatica; 2006 Dec; 60(5):403-10. PubMed ID: 17217095
[TBL] [Abstract][Full Text] [Related]
36. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.
Hadjigeorgiou GM; Xiromerisiou G; Gourbali V; Aggelakis K; Scarmeas N; Papadimitriou A; Singleton A
Mov Disord; 2006 Apr; 21(4):534-9. PubMed ID: 16250025
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E polymorphism in elderly east Africans.
Sayi JG; Patel NB; Premkumar DR; Adem A; Winblad B; Matuja WB; Mtui EP; Gatere S; Friedland RP; Koss E; Kalaria RN
East Afr Med J; 1997 Oct; 74(10):668-70. PubMed ID: 9529753
[TBL] [Abstract][Full Text] [Related]
38. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.
Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R
Ann Neurol; 2001 May; 49(5):665-8. PubMed ID: 11357958
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E epsilon4 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with pick- or microvacuolar-type histology.
Pickering-Brown SM; Owen F; Isaacs A; Snowden J; Varma A; Neary D; Furlong R; Daniel SE; Cairns NJ; Mann DM
Exp Neurol; 2000 Jun; 163(2):452-6. PubMed ID: 10833320
[TBL] [Abstract][Full Text] [Related]
40. [Association between cytochrome P-450 enzyme gene polymorphisms and Parkinson's disease].
Wang J; Liu Z; Chen B
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):585-7. PubMed ID: 11798822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
